Anxiety and Depression in Women Newly Diagnosed with Breast Cancer and Waiting for Surgery: Prevalence and Associations with Socio-Demographic Variables
Overview
Authors
Affiliations
Cancer is a threatening-life disease with a significant psychological burden. The psychological morbidity varies according to the phases of the illness and is influenced by multiple socio-demographic factors, that are useful to consider in order to identify the categories of patients most at risk of developing psychiatric disorders. The present study analyzes, in a sample of women newly diagnosed with breast cancer, the relationships between their levels of anxiety and depression and several socio-demographic characteristics. The study was cross-sectional. : Four hundred and seventy eight women newly diagnosed with breast cancer completed the Hospital Anxiety and Depression Scale during the pre-surgical phase. : Findings show that almost 40% of the sample had clinically relevant anxious symptoms and about a quarter of the sample had significant depressive symptoms. Their prevalence was higher in widows. Moreover, depressive symptoms were higher in older women and anxious symptoms were higher in patients with a lower educational level. In the pre-surgical phase, women can suffer from clinically relevant anxiety and depression, especially the widows, older women, and women with a lower educational level. : Identifying the most psychologically vulnerable patients, due to specific socio-demographic characteristics, is essential in order to provide adequate psycho-oncological treatments to the categories of patients, who are most at risk of developing psychopathological concerns.
The prevalence of anxiety symptoms/disorders in cancer patients: a meta-analysis.
Amiri S Front Psychiatry. 2024; 15:1422540.
PMID: 39619339 PMC: 11605443. DOI: 10.3389/fpsyt.2024.1422540.
Yu W, Wang H, Huda N, Yen Y, Liu Y, Li C Curr Oncol. 2024; 31(10):5802-5820.
PMID: 39451735 PMC: 11506764. DOI: 10.3390/curroncol31100431.
Leo C, Cheng L, Lam X, He H Breast Cancer Res Treat. 2024; 205(3):425-438.
PMID: 38492162 DOI: 10.1007/s10549-023-07216-3.
Engel S, Jacobsen H, Reme S PLoS One. 2023; 18(6):e0287641.
PMID: 37352256 PMC: 10289430. DOI: 10.1371/journal.pone.0287641.
Al-Jabbar M, Alshahrani M, Senan E, Ahmed I Diagnostics (Basel). 2023; 13(10).
PMID: 37238243 PMC: 10217631. DOI: 10.3390/diagnostics13101753.